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Abstract 
Background: In the visceral leishmaniasis (VL), parasites reside in reticuluendothelial system, mainly in macrophages. 
Endothelial Selectin (E-selectin) might play an important role in leukocyte-endothelium interactions and inflammatory cell 
recruitment. The aim of this study was determining E-selectin level and its polymorphism in three groups, patients, 
seropositive and healthy individuals.  
Methods: Serum soluble E-selectin levels as well as 2 polymorphisms of E-selectin (Ser128Arg and Leu554Phe) were 
measured in a cohort of patients with documented VL (n=64), a healthy control group (n=74) and a seropositive for VL but 
without any symptoms (n=81). Circulation concentration of E-selectin levels was measured by ELIS. The amplification 
refractory mutation system (ARMS)-PCR procedure was used for detecting polymorphisms. 
Results: The mean of E-selectin levels significantly differed between three groups (P<0.026), and were increased in pa­
tients in comparison with other groups. Difference was more considerable between two groups of patients and healthy ones 
(patients 92.8 ng/ml; healthy individuals 71.9 ng/ml). Polymorphisms were associated with soluble E-selectin levels and 
altogether explained 14.4%, 7.2%, and 8.7% in patients, seropositive and seronegative healthy individuals, respectively. 
Distribution of polymorphisms of 128Ser/Arg and 554Leu/Phe among three groups was not different significantly; however, 
there was a considerable arrangement in distribution of Ser128Arg polymorphism and 128Arg allele in healthy group was 
more than two fold of patients (55% against 20%).   
Conclusion: The association between soluble E-selectin levels and visceral leishmaniasis suggests that this molecule might 
have significant role in the inflammatory process in VL. Moreover, frequency of 128Arg allele in healthy group was higher 
than patients. 
 
Keywords: Soluble E-selectin, Gene Polymorphism, Visceral Leishmaniasis, Human, ARMS-PCR, Ser128Arg, 554Leu/Phe  
Introduction 
 
Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1, E-selectin) belongs to the selec-
tin family of adhesion molecules. Together with 
LECAM-1 (L-selectin) and GMP-140 (P-selec­
tin), E-selectin mediates the initial interactions 
of leukocytes and platelets with endothelial 
cells (1). The individual members of the selec­
tins are mediated by prefixes, which were cho­
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sen according to the cell type where the mole­
cules were first identified: L-selectin is expre­
ssed on most types of leukocytes, E-selectin is
expressed on activated endothelium, and P-selectin 
was first found in storage granules of platelets 
and is also expressed by endothelial cells. 
As mentioned, together with GMP-140, E-selec­
tin is expressed on cytokine-activated endothelial 
cells, and contributes to the adhesion of still
resting leukocytes to the endothelium (2, 3). 
The circulating form or soluble (sE-selectin) of
this selectin excrete chemo-tactical signals on 
neutrophils and additionally activates the 2­
integrins–sEselectin assists in preparing the 
migration capacity of this cells (4). 
Determination of sE-selectin could provide
more detailed insights into the pathological
modifications during various diseases (5). The
E-selectin mediates the interaction of funda­
mental role in the pathogenesis of coronary
disease (6). Double-knockout mouse experiments 
suggested that E-selectin plays an essential role 
in both early and advanced stages of atheroscle­
rotic lesions development and that mutation in
cellular adhesion molecules like E-selectin may 
act as genetic risk factors for coronary athe­
rosclerosis (7). Additionally, the involvement
of E-selectin in cardiovascular disease is sug­
gested by the fact that it is expressed only in 
activated endothelial cells (8). 
The E-selectin polymorphism S128R has been 
associated with the presence of angiographic 
coronary artery disease (9), myocardial infarc­
tion (10), end-stage renal disease in patients with
IgA nephropathy and ischemic cerebrovascular 
disease in different populations and different
ethnic groups (11, 12). The role of some intra­
cellular adhesion molecules-1 (ICAM-1) have 
been studied and confirmed implicated in the 
cytoadherence process (13, 14). However, no
previous studies are available on possible as­
sociation of this polymorphism with visceral
leishmaniasis amongst different ethnic groups,
and the correlation of selectins' level with this 
infection, that is L. infantum species prevalent  
in this region. 
Therefore, the aim of this investigation was to 
evaluate the potential relevance of E-selectin 
S128R and Leu554Phe genetic polymorphisms
for symptomatic visceral leishmaniasis and 
asymptomatic individuals, as well as the level 
of soluble E-selectin in the VL infections, using 
the Iranian population as a model. 
Materials and Methods  
Samples collection 
This investigation was conducted from 2005­
2006 in East Azerbaijan, North West of Iran. In
a comparative case-control study, three groups
of individuals were recruited for present study 
by convenience sampling from East Azerbaijan
health centers. The patient group comprised 64 
clinically and paraclinically confirmed visceral
leishmaniasis, majority were <10 years old. 
The inclusion criteria for VL were the presence 
of main signs and symptoms, including fever,
hepatomegaly, splenomegaly, anemia and weight 
loss; serologically positive by Direct Agglu­
tination Test (DAT) and Indirect Fluorescent
Antibody (IFA) with agreement together and 
detecting Leishman bodies in bone marrow
aspiration by direct smear. All bone marrows 
had been done in hospitals and those results 
obtained from patients’ files. 
The parasite strain used for diagnostic tests was 
Iranian strain of L. infantum LON-49 that ob­
tained from Drug Applied Research Center, Ta­
briz University of Medical Science. Antigens
prepared according to methods described pre­
viously (15-19). A titer ≥1:3200 considered as 
positive in DAT (17) and, a titer of ≥1:160 
considered as positive in IFA technique (15). 
Second group comprised 81 serologically posi­
tive for VL by IFA and DA tests, but without 
any signs and symptoms and history of con­
firmed VL disease as well. Third group com­
prised also 74 healthy individuals without any 
history of VL and negative for VL serologically. 
This group was selected from patient’s relatives.
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Two procedures, DAT and IFA were done as
methods has described elsewhere (15, 16).
The E-selectin level determined by ELISA 
procedure using Human sE-selectin ELISA
(BMS205 Version 2, Bender Medsystems, 
Vienna, Austria), as described by manufacturer.
Ten ml of peripheral blood for serum compo­
nents was collected into EDTA glass tubes
from all participants after obtaining their writ­
ten informed consent and allowed to coagulate
overnight at 4 ˚C. Serum level of sE-selectin 
were estimated by a two-site ELISA. DNA was
extracted by using standard salting-out proce­
dure using the Fermentas Co kit, and stored at­
20 in aliquots until required. The proposal was 
approved by Ethics Committee of Chancellor for 
Investigation, Hamadan University of Medical
Sciences.  
Measurement of E-selectin level 
Serum level E-selectin concentration were meas­
ured quantitatively and is reported an ng/ml
using a commercially ELISA kit. Briefly, micro 
wells coated by monoclonal antibody (anti E­
selectin monoclonal antibody). Thereafter,
micro wells filled by 100 ul diluted antigen 
(80µl solution+20µl serum) and properly mixed.
In next step, 50µl prepared appropriate dilution 
of the horseradish peroxidase (HRP)-conju­
gated with monoclonal anti E-selectin antibody 
were added to wells (including sample,
standard and blank). Plate covered by an adhe­
sive plastic cover and incubated for 2h in room
temperature. Then, removed cover and also re­
moved coating solution by washing the plate (3
times) by filling and empty the wells by 300µl 
PBS. The solutions or washes were removed
completely by flicking the plate over a sink and 
the remaining drops were removed by patting 
the plate on a paper towel. Then, 100µl of the 
fresh TMB substrate per well dispensed with a 
multichanel pipette and covered with an
adhesive plastic and incubated for 15 min at
room temperature (in a dark place). Reaction 
was stopped adding 100 µl of stop solution to 
the wells. The absorption measurement was
carried out at 450 nm using a micro titer ELISA
Reader. All samples and standards were run in 
duplicate. 
Detection of the S128R polymorphism 
This was carried out by the amplification
refractory mutation system (ARMS)-PCR.  
The amplification refractory mutation system
(ARMS)-PCR or allele–specific PCR assay has
been widely used for HLA typing at the DNA 
level as well as in other applications. This assay 
can detect up to two cis-location motifs per 
reactions, using forward and reverse sequence
specific primers (20). 
For DNA amplification we used the forward 
primer 5-CTGTACCAATACATCCTGCA-3 and 
reverse primer
5-TCTGACTTCATAGTCTCAGCT-3
designed to amplify a 230 bp fragment of the 
E-selectin gene for S128R, and the forward 
primer 5-TCCTGACATTAGCACCATTTC-3
and reverse primer 
5-CCACACTGAGTTGTACTACTA-3
for F554L polymorphisms (15). Each 25 µl of 
10X reaction buffer with MgCl2, 0.4 nM of
each primer, 200 µM each of deoxynucleoside 
triphosphate in Tris HCl buffer, 0.2 unit Taq 
DNA polymerase and 0.1 µg genetic DNA
template. The mixture was denaturate at 96 ºC
for 1 min, and the PCR reaction was carried out 
for 35 cycles, in a DNA-Technology MCT91 
PCR system (4), under the following conditions: 
denaturation at 96 ºC for 1 min, annealing at 54 ºC
for 45 sec, extension at 72 ºC for 1 min, and 
final extension cycle of 72 ºC for 5 min. The
PCR products were electrophoresed on a 1%
agarose gel and detected with 0.5 µg/ml Ethi­
dium bromide to confirm the correct amplicon
size. The sizes of the amplicons were deter­
mined using the 50-bp ladder (2).  
Genotype frequencies in three groups were
compared by chi-square test multivariable logis­
tic regression was used to study the effect of E­
selectin F554L allele (S128R allele) on VL. All
analysis was performed using SPSS V.13 
statistical analysis software. A two-tailed P value  
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 Fig. 1: Gel electrophoresis of PCR product related to S128R allele
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<0.05 was considered statistically significant.   
 
Results 
 
In a screening program, 96 confirmed patients 
of VL detected amongst 768 individuals. One 
hundred forty two out of 672 samples were 
negative and the rest of samples were positive 
for VL serologically by IFAT with the titers 
1:10 to 1:160. A total of 64 samples of con­
firmed VL, 81 samples seropositive for VL 
without history of clinical disease, and 74 sam­
ples seronegative also without history of VL 
disease were eligible and enrolled for study and 
DNA successfully extracted for amplification. 
The mean of soluble E-selectin in the patients, 
seropositive and seronegative individuals were 
92.8, 69.2, and 74.6 ng/ml, respectively. The 
difference of means between three groups were 
significant statistically by ANOVA test (P<0.026). 
Moreover, the mean of sE-selectin between two 
groups of patients and healthy individuals also
were significant statistically (OR= 2.04, P<0.008). 
E-selectin polymorphisms were associated with
soluble E-selectin levels and altogether ex­
plained 14.4%, 7.2%, and 8.7% in patients,
sero-positive and sero-negative healthy groups 
respectively. Distribution of polymorphisms of 
128Ser/Arg and 554Leu/Phe among three
groups was not different significantly; however, 
there was a considerable arrangement in dis­
tribution of Ser128Arg polymorphism and,
128Arg allele in healthy group was more than 
two fold of patient's group (55% against 20%).
The PCR product related to S128R and 554F/P 
alleles showed in the Fig. 1 and 2. 
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Fig. 2: Gel electrophoresis of PCR product related to 554L/P allele
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Discussion 
This study showed high amount of E-selectin in
VL patients. However, distribution of different 
alleles had not considerable differences be­
tween patients and health individuals. Different
studies have demonstrated markedly elevated 
levels of the soluble E-selectin during the 
course of severe cerebral Plasmodium falcipa-
rum infection (21-23), and some other proto­
zoan infections (24, 25), or cardiovascular prob­
lems such as coronary heart disease (26), car­
diovascular damages in central obese subjects 
(27), myocardial infarction (10), and also in the 
SLE (28). It also have studied in different
population and ethnic groups, such as Arabs (5), 
Chinese (7), Japanese (12, 29), and indicated
relatively controversial results (30). Genetic 
mutations and polymorphisms are known to be
risk factors for various infectious diseases and 
especially cardiovascular diseases, such as
malaria, atherosclerosis, coronary angioplasty,
and have been extensively studied for their
potential association with atherogenic vascular 
diseases (31, 32). Similarly, mutations in adhe­
sion molecules and their association with cardi­
ovascular disease, in some cases as a side effect 
of some helminthic infections such as schistoso­
miasis and onchocerciasis, have been recently
investigated (33-35). In the present study, we
demonstrated the concentration of E-selectin in 
the confirmed visceral leishmaniasis in an en­
demic area for this disease.  
Visceral leishmaniasis could assume as an in­
flammatory infection, with a chronic process.
The importance of E-and P-selectin in recruit­
ment of T lymphocytes to inflamed tissues is 
less well understood. E-selectin may be espe­
cially important for T-lymphocyte migration to 
cutaneous inflammation, such as cutaneous leish­
maniasis, because a subset of T cells found 
enriched in human inflammatory dermatoses
express a specific ligand for E-selectin (36). 
Although many studies suggest a role for these 
selectins in T lymphocytes or lymphoblast re­
cruitment, the contribution of E-and P-selectin 
to resting T lymphocyte migration to sites of
inflammation such as the skin and or different
27 
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visceral organs, such as a process that occur for 
visceral disseminated infection by Leishmania, 
had not been documented till now (37). Al­
though, some workers demonstrated that, CD4
(+) T cells recruited to the cutaneous compart­
ment during infection with Leishmania major 
express P-and E-selectin ligands and, expres­
sion of P-and E-selectin ligands correlates with 
activated Leishmania-specific Th1 cells and is 
depend upon IL-12 (38). 
Recent attentions has focused mainly on the 
inflammatory components, such as TNF α, 
TNF β and those polymorphism, TGF α, TGF β
and those polymorphism, interleukin 1 system
polymorphism, CD 14 polymorphism and
different adhesion proteins in the various infec­
tious diseases (30). Several of the polymor­
phisms (for example, those for TNF α and β, 
TGF β1, IL 1, CD 14, and E selectin) have been
found to be functional-that is, to have direct
effects on gene transcription and protein func­
tion. Additionally, the small contribution of a
single novel polymorphism to the overall risk 
of a multifactorial disorder, such as IHD (and 
not simple infections) may be obscured by the 
presence of one or more dominant classical risk
factors. Several reports support this possibility 
(for example, association between CD 14 va­
riants and myocardial infarction, in normoten­
sive and non-smoking patients or in the gener­
ally low risk Japanese population, or between E 
selectin or PECAM 1 polymorphisms and coro­
nary atherosclerosis in young, non-diabetic,
normotensive groups). Prospectively designed
studies and the analysis of haplotypes may
overcome some of limitations of population
studies. Another way to confront these limita­
tions is through careful phenotypic characte­
rization of patients, since a new genetic risk
factor is more likely to emerge within homo­
geneous groups of patients in whom it has a
similar role. Identifying such homogeneous
groups may be difficult and may require rigor­
ous control not only of age, sex, race, and eth­
nic grouping, but also of clinical features and
biochemical markers linked to specific patho­
genic mechanisms. 
In spite of such a limitations, this study con­
firmed different distribution of some alleles in
patients group in comparison to healthy ones, 
as well as higher level of soluble E-selectin in 
patients.  
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